39.32 USD
↗ 1.34 (3.53%)AT CLOSE (11:59 AM EDT)
Novo-Nordisk A/S
NVONYSE • USD
39.37
↗ 0.06 (0.15%)
POST MARKET (AS OF 06:50 PM EDT)
Post Market
AS OF 06:50 PM EDT
39.37
↗ 0.06 (0.15%)
Market: OPEN
Open?$39.13
High?$39.41
Low?$38.73
Prev. Close?$37.98
Volume?20.0M
Avg. Volume?N/A
VWAP?$39.11
Bid / Ask
Bid?$39.35 × 100
Ask?$39.29 × 100
Spread?-$0.06
Midpoint?$39.32
Valuation & Ratios
Market Cap?166.5B
Shares Out?3.4B
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Related Companies
Loading...
News
Profile
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.